Treatment for spinal cord injury using concentrated growth factors
Part of Brain & nervous system, Injuries & trauma clinical trials.
This trial tests if your own concentrated growth factors can help heal a spinal cord injury caused by trauma. You would receive an injection of these factors around the injury site, and the study will check your recovery over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are Chinese, 18 to 60 years old.
- Your spinal cord injury was caused by a trauma (like a fall, car accident, or violence).
- Your injury is graded as ASIA C or D (moderate to incomplete injury).
- Your injury can be acute, subacute, or chronic (any time since injury).
- You can commit to follow-up visits.
- You must not have received any other spinal cord injury treatment like stem cells or growth factors in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment for spinal cord injury that is given through a spinal tap. It is for people with a recent or past spinal cord injury who are at least 18 years old. The treatment may help improve recovery.
This trial tests a combination of stem cells injected into the spinal fluid and a non-invasive spinal cord stimulation device to see if they can improve recovery after a spinal cord injury. It is for people who have had a single traumatic injury between neck and mid-back, 1 to 5 years ago, and are in stable health.
This trial tests if combining electrical stimulation of the spinal cord with personalized physical therapy can help improve leg movement in people with spinal cord injury. It may be an option if you have a stable injury between the upper back and lower back and can commit to frequent therapy sessions.
This trial tests a new gene therapy called STUP-001 that aims to repair spinal cord damage directly. It is for people who have had a traumatic spinal cord injury with complete or near-complete paralysis (AIS-A or B) for at least 6 months.
This trial tests whether a new cell therapy (XS228) can help people with recent spinal cord injuries recover function. The cells are given through a spinal tap and are designed to replace damaged nerve cells.
This phase 1 trial tests a new treatment made from stem cells (XS228) for people who had a spinal cord injury 14 to 60 days ago. Doctors want to see if it's safe and if it might help with recovery.
Hear when a new Spinal Cord Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.